Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Status:
Completed
Trial end date:
2007-02-28
Target enrollment:
Participant gender:
Summary
The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1
esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not
experiencing an HAE attack.
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Complement C1 Inactivator Proteins Complement C1 Inhibitor Protein Complement C1s